Avenzoar Pharmaceuticals

Avenzoar Pharmaceuticals is an early-stage oncology company developing a dual inhibitor for metastatic pancreatic cancer.

Like many biotech startups, they faced the challenge of communicating complex science in a way that resonated with investors.

Referred to us by an investor, Avenzoar came with materials that needed both clarity and re-branding. Acting as investigators and storytellers, we helped uncover their true scientific edge, define clear positioning and develop investor presentation. We also created a new brand identity rooted in the company’s founding story, giving them a distinctive visual presence.

The result is a cohesive narrative and unique brand that balance scientific rigor with business clarity, equipping Avenzoar to approach investors with confidence.